Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+30.0%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+30.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 71.07% |
| 2024 | -57.94% |
| 2023 | -106.85% |
| 2022 | 32.38% |
| 2021 | 8.69% |
| 2020 | -10.21% |
| 2019 | -53.34% |
| 2018 | -290.01% |
| 2017 | -184.48% |
| 2016 | 0.00% |